0
0

Ensuring PBM Competition Act

12/19/2024, 9:06 AM

Summary of Bill HR 6844

Bill 118 hr 6844, also known as the Ensuring PBM Competition Act, is a piece of legislation introduced in the US Congress. The bill aims to promote competition among pharmacy benefit managers (PBMs), which are companies that administer prescription drug benefits for health insurance plans.

The bill seeks to address concerns about the lack of transparency and competition in the PBM industry, which has led to rising drug prices and limited access to affordable medications for many Americans. The legislation would require PBMs to disclose more information about their pricing practices and contracts with pharmacies, as well as to implement measures to prevent anti-competitive behavior.

Additionally, the bill would establish a process for reviewing and approving mergers and acquisitions involving PBMs to ensure that they do not harm competition in the market. This would help to prevent PBMs from gaining too much power and driving up drug prices for consumers. Overall, the Ensuring PBM Competition Act is aimed at promoting a more competitive and transparent PBM industry, which would ultimately benefit consumers by increasing access to affordable prescription medications.

Current Status of Bill HR 6844

Bill HR 6844 is currently in the status of Bill Introduced since December 15, 2023. Bill HR 6844 was introduced during Congress 118 and was introduced to the House on December 15, 2023.  Bill HR 6844's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 6844

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 6844

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 6844

Ensuring PBM Competition Act
Ensuring PBM Competition Act
To amend title XVIII of the Social Security Act to prohibit the Secretary of Health and Human Services from entering into contracts with PDP sponsors of prescription drug plans that have a contract with certain pharmacy benefits managers.

Comments